Amgen's blinatumomab is setting the stage for a bispecific-antibody revival, enabled by new formats that may solve the field's long-standing problems.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Effective flow-through polishing strategies for knob-into-hole bispecific antibodies
Bioresources and Bioprocessing Open Access 14 September 2022
-
Excellent removal of knob-into-hole bispecific antibody byproducts and impurities in a single-capture chromatography
Bioresources and Bioprocessing Open Access 04 July 2022
-
A new approach to produce IgG4-like bispecific antibodies
Scientific Reports Open Access 20 September 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
PowerPoint slides
Rights and permissions
About this article
Cite this article
Garber, K. Bispecific antibodies rise again. Nat Rev Drug Discov 13, 799–801 (2014). https://doi.org/10.1038/nrd4478
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd4478
This article is cited by
-
Excellent removal of knob-into-hole bispecific antibody byproducts and impurities in a single-capture chromatography
Bioresources and Bioprocessing (2022)
-
Effective flow-through polishing strategies for knob-into-hole bispecific antibodies
Bioresources and Bioprocessing (2022)
-
A new approach to produce IgG4-like bispecific antibodies
Scientific Reports (2021)
-
Rejuvenation of tumour-specific T cells through bispecific antibodies targeting PD-L1 on dendritic cells
Nature Biomedical Engineering (2021)
-
A bispecific IgG format containing four independent antigen binding sites
Scientific Reports (2020)
